InvestorsHub Logo
Followers 10
Posts 569
Boards Moderated 1
Alias Born 02/12/2021

Re: tcm55 post# 792

Saturday, 02/26/2022 6:18:34 PM

Saturday, February 26, 2022 6:18:34 PM

Post# of 1102
Memorializing some interesting Comments from Another board @y

Sylvia 2 days ago
$RLF.SW conversation
$NRXP

JJ wants another extension!?!

https://iapps.courts.state.ny.us/nyscef/ViewDocument?docIndex=HiXvj_PLUS_Vs1wAxQm/PPWIalg==

_____________________________________
REPLIES.............

ted 2 days ago
Yes, Saliva, unlike Ram, he's actually busy.
....................

WONG 2 days ago

@ted Ram has acquired APR. Giving instant revenue in-house R&D, a promising pipeline and existing logistical and manufacturing relationships.

Ram acquired Advita and all of there IP and expertise with inhaled Aviptadil. It has already produced an ODD for Sarcoidosis from the FDA and an upcoming patent to treat CIP for cancer patients undergoing immunotherapy treatment.

Ram has created and is moving forward with an ADR program that will uplist Relief to NASDAQ in 2022.

Ram is running trials with both Sentinox and Aviptadil to combat Covid. In Switzerland and Italy.

Ram has helped with the
development and commercialization for ACER-001 that should receive an NDA this June. The deal is as follows:

The companies will split net profits from Acer’s territories 60:40 in favor of Relief. Relief will also license the rights for the rest of the world, where Acer will receive from Relief a 15% net sales royalty on all revenues received in Relief’s territories.

Ram has filed and recieved a trademark for RLF-100TM with the United States Patent and Trademark Office (“USPTO”). Something JJ failed in doing.

Ram has signed a collaboration agreement with InveniAI a U.S. based company that has pioneered the application of artificial intelligence and machine learning across biopharma and other industries, in order to identify promising drug candidates to treat rare and specialty diseases.


Seems he has been busy.

................

Zye of Relief 2 days ago
@ted jj has accomplished nothing he was hired to do. Do we have adequate trial sizes, locations and qualified investigators? NO! Do we have adequate clear cut positive trial data? NO! Do we have an EUA? NO! Do we have BTD? NO! Do we have an NDA? NO! Do we have an EUA in Georgia, data from Goergia, data from inhaled..... DATA AT ALL? NO, EMPHUCKINPHATICALLY NO! Sue him into oblivion, if your contractor did this to you, there would be no hesitation on your part. His failures, and it pains me say this and take this position as I was an enormous fan of sir Bowtie. We are in this place as a direct result of his failures, his and his alone. GREED, SHORTCUTS and FALSEHOODS! LONGER AND STRONGER EVERYDAY-1 ??

My opinion is reflected in my posts, and it is never advice to buy, sell or trade any securities. Do your own due diligence before purchasing anything in the stock market.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRXP News